OncoMed says FDA lifts partial hold on cancer drug trials

(Reuters) - OncoMed Pharmaceuticals Inc said the U.S. Food and Drug Administration lifted a partial hold on patient enrolments for three trials testing its experimental cancer drug, vantictumab.

via Reuters: Health News Read More Here..